Literature DB >> 18615160

Small doses of aripiprazole augmentation of antidepressant treatment: a report of 3 cases.

Takeshi Terao.   

Abstract

Entities:  

Year:  2008        PMID： 18615160      PMCID： PMC2446477          DOI： 10.4088/pcc.v10n0312e

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  5 in total

1.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

2.  Aripiprazole augmentation for treatment of patients with inadequate antidepressants response.

Authors:  Chi-Un Pae; Ashwin A Patkar; Tae-Youn Jun; Chul Lee; Prakash S Masand; In-Ho Paik
Journal:  Depress Anxiety       Date:  2007       Impact factor: 6.505

3.  Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder.

Authors:  George I Papakostas; Timothy J Petersen; Gustavo Kinrys; Alana M Burns; John J Worthington; Jonathan E Alpert; Maurizio Fava; Andrew A Nierenberg
Journal:  J Clin Psychiatry       Date:  2005-10       Impact factor: 4.384

4.  An open-label, rater-blinded, augmentation study of aripiprazole in treatment-resistant depression.

Authors:  Ashwin A Patkar; Kathleen Peindl; Rajnish Mago; Paolo Mannelli; Prakash S Masand
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

5.  The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.

Authors:  Robert M Berman; Ronald N Marcus; René Swanink; Robert D McQuade; William H Carson; Patricia K Corey-Lisle; Arif Khan
Journal:  J Clin Psychiatry       Date:  2007-06       Impact factor: 4.384
  5 in total
  1 in total

1.  An investigation into aripiprazole's partial D₂ agonist effects within the dorsolateral prefrontal cortex during working memory in healthy volunteers.

Authors:  Anna Murphy; Serdar Dursun; Shane McKie; Rebecca Elliott; John Francis William Deakin
Journal:  Psychopharmacology (Berl)       Date:  2016-02-22       Impact factor: 4.530
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.